Ειδήσεις: DIANTHUS | PXAI

Version	Description	Date
8.42	[ADDED SOURCE REGISTRY LIST VIEW]	04/03/2026 16:19
8.41	[LOCALIZED INDEX.PHP MENU AND MODALS TO US ENGLISH]	04/03/2026 16:11
8.40	[TRANSLATED FRONTEND TO US ENGLISH]	04/03/2026 16:10
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:50
8.41	[RESTORED DETAILED SOURCES VIEW (ARTICLES + EVENTS) IN US ENGLISH]	04/03/2026 15:46
8.40	[REVERTED TO STANDARD TABLE LAYOUT (US ENGLISH)]	04/03/2026 15:40
8.39	[FIXED DB CONNECTION SCOPE IN SOURCES LOGIC]	04/03/2026 15:38
8.38	[TRANSLATED SOURCES VIEW TO US ENGLISH]	04/03/2026 15:01
8.37	[FULL FRONTEND TRANSLATION (MENU, FEED, COMMENTS, TTS) TO US ENGLISH.]	04/03/2026 14:58
8.67	[MANUAL OVERRIDE OF GREEK MENU ITEMS]	04/03/2026 13:36
8.66	[NGINX OPTIMIZED MENU FIX]	04/03/2026 13:33
8.65	[FIXED GREEK MENU ITEMS]	04/03/2026 13:32
8.60	[MENU & UI LOCALIZATION TO US ENGLISH]	04/03/2026 13:30
8.50	[FULL TRANSLATION TO US ENGLISH]	04/03/2026 13:27
9.75	[INJECTED EVENT FUSION_SUMMARY INTO FEED LOOPS TO DISPLAY AI TAGS CORRECTLY]	26/02/2026 14:44

20/03 07:32 defenseworld.net

SELLAS Life Sciences Group (NASDAQ:SLS) & Dianthus Therapeutics (NASDAQ:DNTH) Critical Survey

SELLAS Dianthus Life Sciences valuation profitability medical companies

16/03 10:52 defenseworld.net

Dianthus Therapeutics (NASDAQ:DNTH) CAO Sells $3,559,646.18 in Stock

Dianthus Therapeutics CAO sale SEC filing stock price market cap biotech

16/03 10:52 defenseworld.net

Insider Selling: Dianthus Therapeutics (NASDAQ:DNTH) EVP Sells $2,756,468.40 in Stock

Dianthus Therapeutics insider selling stock sale EVP SEC filing Nasdaq

16/03 10:52 defenseworld.net

Dianthus Therapeutics (NASDAQ:DNTH) CEO Sells $10,016,587.82 in Stock

Dianthus Therapeutics CEO sale SEC filing stock price market cap P/E ratio

16/03 10:52 defenseworld.net

Dianthus Therapeutics (NASDAQ:DNTH) CEO Sells $10,016,587.82 in Stock

Dianthus Therapeutics CEO sale SEC filing stock price market cap P/E ratio

Loading...